Whole Live Covid-19 Virus, Not Just Fragments, Found in Hospital Aerosols

(p. A4) Skeptics of the notion that the coronavirus spreads through the air — including many expert advisers to the World Health Organization — have held out for one missing piece of evidence: proof that floating respiratory droplets called aerosols contain live virus, and not just fragments of genetic material.

Now a team of virologists and aerosol scientists has produced exactly that: confirmation of infectious virus in the air.

“This is what people have been clamoring for,” said Linsey Marr, an expert in airborne spread of viruses who was not involved in the work. “It’s unambiguous evidence that there is infectious virus in aerosols.”

For the full story, see:

Apoorva Mandavilli. “Scientists Find Respiratory Droplets in Hospital Air.” The New York Times (Wednesday, August 12, 2020): A4.

(Note: ellipsis, and bracketed date, added. The online version say that the New York print version had the title “Scientists Retrieve Live Virus From Hospital Air.” My National print version had the title “Scientists Find Respiratory Droplets in Hospital Air.”)

(Note: the online version of the story has the date Aug. 11, 2020, and has the title “‘A Smoking Gun’: Infectious Coronavirus Retrieved From Hospital Air.”)

Former FDA Commissioners Urge Early “Emergency Use Authorization” for Covid-19 Vaccine

(p. A17) As former FDA commissioners, we are confident in the FDA’s career scientists to oversee vaccine development rigorously.

If a Covid vaccine clears this process, it could be made available initially to specific groups of people through an Emergency Use Authorization. This emergency authority enables the FDA to make products available before a full application is approved by the agency. Congress created the emergency-use pathway as part of the Project BioShield Act of 2004, which provided for the development of medical countermeasures against chemical, biological, radiological and nuclear threats. Following 9/11 and anthrax, lawmakers expected an urgent need for such defenses.

After the 2009 swine flu, Congress expanded this pathway in the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013, a bipartisan measure aimed at preparing the country to weather a pandemic. The law streamlined the application process for emergency use, expanded the classes of drugs eligible, and broadened the testing the FDA could require.

. . .

This authority enables the staged entry of a vaccine. It’s unlikely that a Covid-19 vaccine will receive full approval and broad distribution right away. Instead, the FDA will probably authorize vaccines for use in targeted groups of people at high risk from Covid and most likely to benefit from the vaccine. For them, it may make sense to provide access to the vaccine before long-term follow-up studies that address very remote risks.

This might include health-care providers or first responders, who face greater exposure, or older people, who are more prone to severe complications if infected.

. . .

This process exists precisely to deal with public-health emergencies like Covid-19. It isn’t a lower standard for FDA approval. It’s a more tailored, flexible standard that helps protect those who need it most while developing the evidence needed to make the public confident about getting a Covid-19 vaccine.

For the full commentary, see:

Mark McClellan, and Scott Gottlieb. “How ‘Emergency Use’ Can Help Roll Out a Covid Vaccine.” The Wall Street Journal (Monday, September 15, 2020): A17.

(Note: ellipses added.)

(Note: the online version of the commentary has the date Sep. 13, 2020, and has the same title as the print version.)

A Forgotten Language Will Be Easier to Re-Learn

(p. 12) What makes sociolinguistics a subject worth engaging with are the surprises, and Kinzler’s book is full of them. She reveals the extent to which language imprints our brains and how we are neurologically programmed to be sensitive to it. Even if we lose a language after early childhood and no longer speak it in adulthood, learning it will be easier because of deep-seated neural settings permanently etched by that first language.

For the full review, see:

John McWhorter. “Fuggedaboutit!” The New York Times Book Review (Sunday, August 2, 2020): 12.

(Note: the online version of the review has the date July 21 [sic], 2020, and has the title “The Biases We Hold Against the Way People Speak.”)

The book under review is:

Kinzler, Katherine D. How You Say It: Why You Talk the Way You Do―and What It Says About You. New York: Houghton Mifflin Harcourt, 2020.

Amazon Adds 100,000 Fulltime, Nonseasonal Jobs That Include Benefits and Bonuses

(p. A1) Amazon.com Inc. plans to hire 100,000 additional employees in the U.S. and Canada, continuing a rapid expansion that began as the coronavirus pandemic forced many people to stay home and shop online for work and other necessities.

. . .

New jobs will be added at dozens of Amazon locations (p. A6) paying at least $15 an hour and including benefits and signing bonuses of as much as $1,000 in some cities. Hiring for the jobs has already begun. The positions are all nonseasonal, Amazon said.

For the full story, see:

Ben Otto, and Sebastian Herrera. “Amazon Ramps Up Hiring Plans, Adds 100,000 New Jobs.” The Wall Street Journal (Tuesday, September 15, 2020): A1 & A6.

(Note: ellipsis added.)

(Note: the online version of the story was updated Sep. 14, 2020, and has the title “Amazon to Hire 100,000 in U.S. and Canada.”)

Russia Approves Covid-19 Vaccine Before Completing Phase 3 Clinical Trial

(p. A6) MOSCOW — Russia has become the first country in the world to approve a vaccine for the coronavirus, President Vladimir V. Putin announced on Tuesday, though global health authorities say the vaccine has yet to complete critical, late-stage clinical trials to determine its safety and effectiveness.

Mr. Putin, who told a cabinet meeting on Tuesday [Aug. 11, 2020] morning that the vaccine “works effectively enough,” said that his own daughter had taken it. And in a congratulatory note to the nation, he thanked the scientists who developed the vaccine for “this first, very important step for our country, and generally for the whole world.”

. . .

If Russian scientists have taken an unorthodox route to the coronavirus vaccine, it would not be the first time. Back in the 1950s, a team of researchers tested a promising, and ultimately successful, polio vaccine on their own children.

For the full story, see:

Andrew E. Kramer. “Putin Says Russia Is First to Approve Vaccine, but Skepticism Abounds.” The New York Times (Wednesday, August 12, 2020): A6.

(Note: ellipsis, and bracketed date, added.)

(Note: the online version of the story was updated Aug. 11, 2020, and has the title “Russia Approves Coronavirus Vaccine Before Completing Tests.”)

Chinese Communists Try to Intimidate U.S. Universities

(p. A1) The effect of the new national-security law that China imposed on Hong Kong is extending far beyond the territory to American college campuses.

Classes at some elite universities will carry a warning label this fall: This course may cover material considered politically sensitive by China. And schools are weighing measures to try to shield students and faculty from prosecution by Chinese authorities.

. . .

(p. A6) “We cannot self-censor,” said Rory Truex, an assistant professor who teaches Chinese politics at Princeton. “If we, as a Chinese teaching community, out of fear stop teaching things like Tiananmen or Xinjiang or whatever sensitive topic the Chinese government doesn’t want us talking about, if we cave, then we’ve lost.”

. . .

Concerns about China’s influence on academics around the world have grown over the past two decades, as some educational institutions set up campuses in China and many increasingly rely on fees paid by Chinese students, who account for more foreign students in the U.S. than any other country.

There are indications that Chinese students in the U.S. could fall afoul of Chinese laws. A University of Minnesota student was sentenced to six months’ imprisonment after returning home to the Chinese city of Wuhan last year. He was convicted of “provocation” for tweets he wrote while studying in the U.S. that allegedly mocked Chinese leaders.

For the full story, see:

Lucy Craymer. “Hong Kong Law Makes Top U.S. Colleges Wary.” The Wall Street Journal (Thursday, August 20, 2020): A1 & A6.

(Note: ellipses added.)

(Note: the online version of the story was updated Aug. 19, 2020, and has the title “China’s National-Security Law Reaches Into Harvard, Princeton Classrooms.”)

“Pessimism of the Intellect and Optimism of the Will”

(p. C4) Advertisers may have been peddling baubles or junk food, but their cash funded serious journalism — the kind that could afford to send a reporter to, say, every municipal board meeting. “People knew that,” the former editor of the once mighty Youngstown Vindicator told Sullivan, “and they behaved.” This watchdog function had tangible benefits for subscribers and nonsubscribers alike. “When local reporting waned,” Sullivan writes, “municipal borrowing costs went up.” Local news outlets provide the due diligence that bondholders often count on. Without the specter of a public shaming, corruption is freer to flourish.

. . .

“Ghosting the News” concludes with a soaring quote from the Italian theorist Antonio Gramsci about “pessimism of the intellect and optimism of the will,” but the local reporter in Sullivan follows it up with a more immediate analogy: Even if no one seems to be coming to the rescue while your house is on fire, you still have to “get out your garden hose and bucket, and keep acting as if the fire trucks are on the way.”

For the full review, see:

Jennifer Szalai. “Books of the Times; Another Endangered Species.” The New York Times (Thursday, July 30, 2020): C1 & C4.

(Note: ellipsis added.)

(Note: the online version of the review has the date July 26, 2020, and has the title “Books of the Times; Yes, Fake News Is a Problem. But There’s a Real News Problem, Too.”)

The book under review is:

Sullivan, Margaret. Ghosting the News: Local Journalism and the Crisis of American Democracy. New York: Columbia Global Reports, 2020.

Shanghai Immunologist Says Phase 1 and Phase 2 Tests Show Chinese Vaccine Is Safe and “Highly Likely” to Protect Against Covid-19

(p. A8) The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

. . .

Tao Lina, a former immunologist with the Shanghai CDC, said in an interview that it makes sense for authorities to approve the usage of Chinese vaccines that have proved safe during the first two phases of clinical trials, given the scale of the Covid-19 crisis. Unlike medical drug treatments, vaccines work by triggering a person’s own immunity, he said. “I’m not at all worried about the safety of the vaccines,” Mr. Tao said.

While the level of efficacy of the Chinese vaccines being used including those of Sinopharm isn’t yet clear, Mr. Tao said the Chinese vaccines’ ability to induce the body to produce antibodies during previous clinical trials meant that they were highly likely to confer some degree of protection from the virus.

For the full story, see:

Chao Deng, and Rory Jones. “U.A.E. Approves Use of China-Made Covid-19 Vaccine.” The Wall Street Journal (Wednesday, September 16, 2020): A8.

(Note: ellipsis added.)

(Note: the online version of the story was updated Sep. 15, 2020, and has the title “In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval.”)

600-Year-Old Ginkgo Trees Are as Vigorous as 20-Year-Old Ginkgo Trees

(p. D2) . . . a January [2020] study on ginkgo trees, which can live for over a thousand years . . . found that 600-year-old ginkgos are as reproductively and photosynthetically vigorous as their 20-year-old peers. Genetic analysis of the trees’ vascular cambium — a thin layer of cells that lies just underneath the bark, and creates new living tissue — showed “no evidence of senescence,” or cell death, the authors wrote.

For the full story, see:

Cara Giaimo. “Holding On; Can Trees Live Forever? A New Study Adds Kindling to the Debate.” The New York Times (Tuesday, August 4, 2020): D2.

(Note: ellipses, and bracketed year, added.)

(Note: the online version of the story was updated July 27, 2020, and has the title “Can Trees Live Forever? New Kindling for an Immortal Debate.”)

The January 2020 study mentioned above is:

Wang, Li, Jiawen Cui, Biao Jin, Jianguo Zhao, Huimin Xu, Zhaogeng Lu, Weixing Li, Xiaoxia Li, Linling Li, Eryuan Liang, Xiaolan Rao, Shufang Wang, Chunxiang Fu, Fuliang Cao, Richard A. Dixon, and Jinxing Lin. “Multifeature Analyses of Vascular Cambial Cells Reveal Longevity Mechanisms in Old Ginkgo biloba Trees.” Proceedings of the National Academy of Sciences 117, no. 4 (Jan. 28, 2020): 2201-10.

China’s “Emergency-Use” Rule Allows Vaccinating Hundreds of Thousands Against Covid-19

(p. A1) A Chinese pharmaceutical company has injected hundreds of thousands of people with experimental Covid-19 vaccines, as its Western counterparts warn against administering mass vaccinations before rigorous scientific studies are complete.

China National Biotec Group Co., a subsidiary of state-owned Sinopharm, has given two experimental vaccine candidates to hundreds of thousands of people under an emergency-use condition approved by Beijing in July [2020], the company said this week.

For the full story, see:

Chao Deng. “China Tests Vaccines on Hundreds of Thousands.” The Wall Street Journal (Saturday, September 12, 2020): A1 & A8.

(Note: bracketed year added.)

(Note: the online version of the story was updated September 12, 2020, and has the title “China Injects Hundreds of Thousands With Experimental Covid-19 Vaccines.”)

”There Was a Great Marxist Called Lenin”

(p. C11) Robert Conquest (1917-2015) was what used to be called a Renaissance man. He was so good at everything he did—soldier, diplomat, historian and poet—that I wouldn’t be surprised to learn he also left behind a few sonatas and paintings in oil. His histories of the Soviet Union’s failures and atrocities include “The Great Terror” (1968) and “The Harvest of Sorrow” (1986), meticulously researched and humane investigations of a criminal state, surely among the major historical achievements of the 20th century. His television documentary series, “Red Empire” (1990), distills this work and makes grimly compelling viewing.

But Conquest first came to readers’ attention as a poet of sophistication and grace, . . .

. . .

”There was a great Marxist called Lenin,
Who did two or three million men in;
That’s a lot to have done in
But where he did one in
That grand Marxist Stalin did ten in.”

For the full review, see:

David Mason. “The Impervious Dream.” The Wall Street Journal (Saturday, Aug. 22, 2020): C11.

(Note: ellipses added; the limerick in quotation marks is by Robert Conquest.)

(Note: the online version of the review has the date Aug. 21, 2020, and has the title “‘Robert Conquest: Collected Poems’ Review: The Impervious Dream.”)

The book under review is:

Conquest, Robert. Collected Poems. New York: The Waywiser Press, 2020.